Albuquerque supplements retailer sentenced for performance enhancing drugs
The Department of Justice has sentenced the owner of Albuquerque-based Allstar Nutrition to three years’ probation for selling misbranded performance enhancing drugs.
Archives for September 8, 2022
Study: How early maternal dietary intakes affect biological aging in children
The first 1000 days of life—from conception to two years of age—represents a crucial period in which maternal diet and other exposures might influence children’s health.
‘Total microbiome company’ is bringing microbiome innovation to the masses
BIOHM has unveiled a number of services for gut health companies and developers looking to advance their offerings.
UK ‘one step closer’ to adding folic acid to flour for foetal health
A UK-wide consultation on the amount of folic acid to be added to flour to help prevent neural tube defects in the womb is now underway.
Kibbutz Yotvata and Brevel sign MOU to build ‘largest microalgae fermentation reactors of their kind’
The Memorandum of Understanding (MOU) is an agreement to build a facility for the cultivation and production of microalgae-based protein and related products for the food and beverage industry.
Citrus-Pomegranate complex may support physical fitness and mental well-being in older people: RCT
A combination of extracts from citrus and pomegranate may improve handgrip strength, a measure of physical fitness, and cognitive functioning for memory, learning, and concentration, says a new study from The Netherlands.
Probiotic L. casei 63 may limit sarcopenia in the elderly: Study
Supplementation with Lacticaseibacillus casei 63 (L. casei 63) may help reduce sarcopenia in frail elderly people by promoting insulin sensitivity, metabolic efficiency, and muscle protein anabolism, according to a French study.
Potential therapy: Vitamin B12 supplementation could improve NAFLD patient condition – RCT
Oral vitamin B12 supplementation, specifically 1000 μg cyanocobalamin daily, for 12 weeks demonstrated improved serum liver enzyme, blood glucose and malondialdehyde levels in patients suffering from non-alcoholic fatty liver disease (NAFLD).